8-K: SelectQuote Reports Mixed Q4 FY26 Results, Guides for FY27 Cash Flow Growth

SelectQuote, Inc. announced its fourth quarter and full fiscal year 2026 results, highlighting a significant improvement in operating cash flow and strong performance in its Senior segment, while also reporting a net loss for the quarter and a decrease in full-year Adjusted EBITDA.

Summary

• SelectQuote, Inc. reported financial results for the fourth quarter and full fiscal year ended June 30, 2026.
• Consolidated revenue for Q4 FY2026 was $321.7 million, a decrease from $345.1 million in Q4 FY2025.
• The company reported a net loss of $16.8 million for Q4 FY2026, compared to a net income of $12.9 million in Q4 FY2025.
• Adjusted EBITDA for Q4 FY2026 was $11.9 million, an increase from $2.7 million in Q4 FY2025.
• For the full fiscal year 2026, consolidated revenue was $1.6 billion, an increase from $1.5 billion in FY2025.
• Full-year FY2026 net income was $62.2 million, an increase from $47.6 million in FY2025.
• Full-year FY2026 Adjusted EBITDA was $109.1 million, a decrease from $126.3 million in FY2025.
• Operating cash flow for FY2026 was $31.9 million, a significant improvement from a use of $11.7 million in FY2025, representing a $44 million increase.
• Guidance for FY2027 includes expected revenue between $1.35 billion and $1.45 billion, Adjusted EBITDA between $90 million and $115 million, and operating cash flow exceeding $60 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed result. While the company shows improved operating cash flow and strong performance in its Senior segment, the overall revenue and net income/loss for the quarter and year show declines or losses compared to the previous year, with a notable net loss in Q4 FY2026.

Positives

• Significant improvement in operating cash flow, with a $44 million increase year-over-year for FY2026, reaching $31.9 million.
• The Senior segment delivered strong results with an Adjusted EBITDA margin of 26% for FY2026, exceeding the long-term target of 20% for the fourth consecutive year.
• Healthcare Services segment's SelectRx business is exiting FY2026 with a run-rate Adjusted EBITDA of nearly $50 million.
• Technology-enabled workstream efficiencies are expected to drive annual expense savings of over $30 million starting in FY2027.
• Projected doubling of operating cash flow in FY2027 to over $60 million, with free cash flow generation of around $50 million.
• Q4 FY2026 Adjusted EBITDA increased to $11.9 million from $2.7 million in Q4 FY2025.
• Full-year FY2026 net income increased to $62.2 million from $47.6 million in FY2025.

Negatives

• Consolidated revenue for Q4 FY2026 decreased to $321.7 million from $345.1 million in Q4 FY2025.
• Reported a net loss of $16.8 million for Q4 FY2026, a reversal from a net income of $12.9 million in Q4 FY2025.
• Consolidated Adjusted EBITDA for the full fiscal year 2026 decreased to $109.1 million from $126.3 million in FY2025.
• Senior segment revenue decreased by 12% in Q4 FY2026 and 4% for the full year FY2026 compared to the prior year.
• Healthcare Services segment revenue decreased by 10% in Q4 FY2026 compared to the prior year.
• Total approved Medicare Advantage policies decreased by 15% in Q4 FY2026 and 4% for the full year FY2026.
• The company's current assets decreased from $341.0 million to $350.9 million, while cash, cash equivalents, and restricted cash decreased from $35.7 million to $20.7 million.

Risks

• Reliance on a limited number of insurance carrier partners and potential termination of relationships.
• Existing and future laws and regulations affecting the health insurance market.
• Changes in health insurance products offered by carriers and the overall market.
• Insurance carriers offering products and services directly to consumers.
• Changes to commissions paid by insurance carriers and underwriting practices.
• Competition from other brokers, online brokers, and carriers selling directly.
• Downturns in the senior health, life, automotive, and home insurance industries.
• Disruptions or failures of technological infrastructure and platform, and cybersecurity breaches.

Future Outlook

For fiscal year 2027, SelectQuote expects revenue to be in the range of $1.35 billion to $1.45 billion, Adjusted EBITDA between $90 million and $115 million, and operating cash flow to exceed $60 million. The company anticipates doubling operating cash flow and generating approximately $50 million in free cash flow.

Management Comments

• "It was a highly successful 4th quarter and full-year fiscal 2026 for our business."
• "Our Senior Medicare Advantage distribution business excelled through another turbulent year for the industry."
• "SelectQuote remained the reliable partner of choice."
• "We have high confidence in our Senior platforms ability to generate durable returns across a range of Medicare Advantage environments and view fiscal 2027 as an important year to further compound cash flow while remaining disciplined in our growth investments as carrier profitability improves."
• "We also increasingly realized our goal to scale Healthcare Services profitability and cash flow through our SelectRx business."
• "We are excited to exit fiscal 2026 with run-rate Adjusted EBITDA of nearly $50 million, which will increasingly drive operating cash flow and ultimately accrue value to our shareholders."
• "As we have emphasized, our highest strategic priority is to deliver shareholder value through growth in profitability and scaled cash flow."
• "Exiting 2026, we have successfully implemented technology-enabled workstream efficiencies that we expect will drive annual expense savings of over $30 million."

Industry Context

StockSavvy.ai notes that SelectQuote operates in the dynamic health insurance market, particularly Medicare Advantage, which is subject to frequent policy changes by carriers. The company's ability to maintain strong margins in its Senior segment despite these changes highlights its resilience. The growth in Healthcare Services, specifically SelectRx, indicates a strategic diversification effort. The projected increase in operating cash flow for FY2027, driven by technology efficiencies, aligns with industry trends towards automation and cost optimization.

Comparison to Industry Standards

• The Senior segment's Adjusted EBITDA margin of 26% for FY2026 is solidly above SelectQuote's long-term operating target of 20%+, indicating strong performance relative to its own benchmarks.
• The company's projected FY2027 operating cash flow of over $60 million represents a significant increase (nearly 88% YoY) from FY2026, suggesting a potential outperformance in cash generation compared to industry peers facing similar market conditions.
• The Revenue/CAC multiple of 6.8X for the twelve months ended June 30, 2026, indicates an efficient customer acquisition strategy relative to revenue generated, though direct industry comparisons are not provided in the filing.
• The company's focus on technology-enabled efficiencies for cost savings of over $30 million in FY2027 is a common strategy across the insurance and healthcare services sectors to improve profitability.

Legal Proceedings

• Potential litigation and other legal proceedings or inquiries are listed as a risk factor.

Stakeholder Impact

• Shareholders: Potential for increased equity value accretion through growth in profitability and scaled cash flow, but offset by Q4 net loss and decreased full-year Adjusted EBITDA.
• Employees: Expected annual expense savings of over $30 million from technology efficiencies may impact workforce planning or structure.
• Customers: Continued focus on providing reliable insurance comparisons and healthcare services.
• Creditors: The company's debt levels and ability to maintain compliance with debt covenants remain a factor.

Next Steps

• Focus on compounding cash flow growth in FY2027.
• Continue to compound cash flow growth in the future through optimization of leverage and funding costs.
• Accelerate equity value accretion through growth in profitability and scaled cash flow.
• Deliver shareholder value in the years ahead.
• Continue to scale Healthcare Services profitability and cash flow.
• Implement technology-enabled workstream efficiencies to drive annual expense savings.

Key Dates

Recommendation

The filing presents a mixed picture. While there's a strong positive trend in operating cash flow improvement and a clear strategy for future cash flow growth driven by technology efficiencies, the Q4 net loss and decline in full-year Adjusted EBITDA are concerning. The Senior segment's resilience is a positive, but the overall revenue decline in the quarter and the continued pressure on Adjusted EBITDA suggest caution. The guidance for FY2027 is optimistic, but the company needs to demonstrate consistent execution to overcome the recent negative trends. Therefore, a 'hold' recommendation is appropriate pending further clarity on sustained profitability and revenue growth.

Keywords

SelectQuote, Medicare Advantage, Healthcare Services, Senior Insurance, Life Insurance, Adjusted EBITDA, Operating Cash Flow, Financial Results